Send feedback

TLE2 p.Ser713=

c.2139C>G · VCV3456841

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
REVEL0.024moderately benign-leaning
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 0.096phastCons 0.75
Overall
CADD3.16PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0164% Middle Eastern · 1/6,082 alleles
Filtering AF 0.00111% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0009%
Overall 0.00167% 27/1,612,152 alleles · ultra-rare exomes 19/1,460,022 · genomes 8/152,130 · joint denominator
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0164% 6,082
Remaining individualsnot grpmax-eligible 0.00641% 15,603
European (non-Finnish) 0.0017% 58,959
African / African-American 0.00134% 74,886
South Asian 0.0011% 90,622

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TLE2
Protein
p.Ser713=
Coding
c.2139C>G
MANE Select
NM_003260
Type
single nucleotide variant
Location
chr19:2997941 (GRCh38)
Gene constraint
LOEUF 1.02 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 68.40
Full TLE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tle2-p-ser713 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown